Abnormal Myocardial Calcium Handling in the Early Stage of Adriamycin Cardiomyopathy

Abstract

Metabolic changes have been shown to precede mechanical abnormalities in the early stages of adriamycin cardiotoxicity. This study examines the early changes in calcium homeostasis and their mechanical implications in a model of adriamycin cardiomyopathy. Hearts isolated from control and adriamycin-treated rats were coronary-perfused and isovolumic left ventricular (LV) pressure, coronary perfusion pressure and calcium transients from aequorin-loaded cardiomyocytes were recorded. Treated rats received three injections of adriamycin (6 mg/kg) for a period of 1 week. They were sacrificed for experiments 1-2 or 4-5 weeks after the final injection. The LV systolic and end-diastolic pressures were similar in both groups at varied external calcium concentrations (0.5-2.0 mM). However, systolic levels of myoplasmic calcium were substantially higher in the adriamycin-treated hearts, the difference being less at higher external calcium concentrations. Similar responses in both groups to paired pulse stimulation, increased stimulation frequency and caffeine (0.5-2.0 mM) were observed. However, adriamycin-treated hearts exhibited a smaller rise in LV developed pressure, as well as in systolic and diastolic calcium levels, in response to elevated coronary perfusion pressure. The elevated intracellular systolic calcium level is suggestive of an early but persistent effect of adriamycin on the calcium release channels of the sarcoplasmic reticulum. That the elevated systolic myoplasmic calcium levels are not accompanied by an increase in inotropy suggests a decrease in myofibrillar calcium sensitivity in this model of the early stage of adriamycin cardiomyopathy.

Cardioprotection mechanism of mangiferin on doxorubicin-induced rats: Focus on intracellular calcium regulation

“…As has been confirmed by many studies, DOX causes marked increase on cytosolic calcium level as a direct effect of disturbed calcium regulation, which in turn causes mitochondrial calcium overload (Kapelko et al, 1996;Zhou et al, 2001). In this study, it was found that MGR treatment was able to ameliorate DOX-induced increase on cytosolic calcium level.…”

Anthracycline-induced chronic cardiotoxicity and heart failure

“…As a result lipid-protein interactions involved in signal transduction pathways are affected [4]. Increased calcium release from sarcoplasmatic reticulum leads to cytosolic calcium overload [5]. The treatment also results in mitochondrial dysfunction with abnormal calcium-ion handling and abnormal energy metabolism [6,7].…”

Left Ventricular Assist Device as Bridge to Recovery for Anthracycline‐Induced Terminal Heart Failure

“…Myocardial damage is believed to be caused by oxidative stress induced in the myocardial cells by redox‐cycling during metabolism of the drug 2 . Different pathophysiologic mechanisms are involved that lead to reduced energy production, abnormal calcium handling, dysfunctional protein synthesis, reduced myofibrillar function, and apoptosis 3–5 . Eventually this causes increasing myocardial wall stress, remodeling, and deteriorating myocardial function as in other types of cardiomyopathy.…”